We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Subcutaneous implantable cardioverter defibrillator: Can it overtake its transvenous counterpart.
- Authors
Savarimuthu, Sugeevan; Roy, Saswata; Obeidat, Mohammed; Harky, Amer
- Abstract
Over the past decade, the emergence of the subcutaneous implantable cardioverter defibrillator (S‐ICD) has provided cardiologists with an option to provide both primary or secondary prevention treatment of sudden cardiac death (SCD) without the associated risks that come with the use of intracardiac leads. S‐ICD may prove to be a useful option in those who are young, have thromboembolic risk, immunodeficiency states, unfavorable anatomy due to adult congenital heart disease (ACHD). This article reviews the existing literature to determine whether S‐ICD can prove to be a safe alternative in comparison to Transvenous implantable cardioverter defibrillator (TV‐ICD) and in which patient population should S‐ICD be considered over TV‐ICD.
- Subjects
THROMBOEMBOLISM risk factors; VEINS; CARDIOLOGISTS; IMPLANTABLE cardioverter-defibrillators; CONGENITAL heart disease; VENTRICULAR tachycardia; CARDIAC arrest; PATIENT safety; DISEASE complications
- Publication
Pacing & Clinical Electrophysiology, 2021, Vol 44, Issue 8, p1413
- ISSN
0147-8389
- Publication type
Article
- DOI
10.1111/pace.14246